The neurogenic bladder.
D001285:Atropine / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects; D005730:Ganglionic Blockers / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009451:Neuroeffector Junction / Q000187:drug effects; D010275:Parasympathetic Nervous System / Q000502:physiology; D013118:Spinal Cord Diseases / Q000150:complications; D016135:Spinal Dysraphism / Q000150:complications; D013564:Sympathetic Nervous System / Q000502:physiology; D014227:Triazines / Q000627:therapeutic use; D001743:Urinary Bladder / Q000294:innervation / Q000502:physiology / Q000503:physiopathology; D001748:Urinary Bladder Neck Obstruction / Q000601:surgery; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D014554:Urination
D005730:Ganglionic Blockers; D014227:Triazines; D001285:Atropine; D003975:Diazepam